206 results
8-K
EX-2.1
ATHXQ
Athersys, Inc / New
8 Jan 24
Entry into a Material Definitive Agreement
7:31am
, research and development, Intellectual Property, supplier lists, records, literature and correspondence. Notwithstanding anything to the contrary
8-K
ATHXQ
Athersys, Inc / New
18 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:00am
, the Company responded to a request for proposal by the Biomedical Advanced Research and Development Authority, an agency within the U.S. Department
424B4
ATHXQ
Athersys, Inc / New
21 Aug 23
Prospectus supplement with pricing info
2:36pm
and we take significant steps to protect its value. We have ongoing research and development efforts through collaborative research activities … to termination of the agreement or delays in collaborative research, development, supply, or commercialization of certain product candidates, or could require
424B3
s0w0jm
8 Jun 23
Prospectus supplement
10:28am
424B3
vv5r18p2 jz1l3vefb
8 Jun 23
Prospectus supplement
10:28am
8-K
EX-99.1
410rk
18 May 23
Athersys Reports First Quarter 2023 Financial Results and Provides Business Update
10:13am
424B5
kzkuif qgf
20 Apr 23
Prospectus supplement for primary offering
2:02pm
8-K
EX-99.1
hwgd3ra
31 Mar 23
Athersys Reports Fourth Quarter and Full Year 2022 Financial Results and Business Highlights
6:43pm